Amgen vs. Alexion Pharmaceuticals - App_33372/2025

The UPC Case App_33372/2025 was filed on 21 Jul, 2025 by the plaintiff Amgen, Amgen AB, Amgen Biofarmaceutica LDA, and others against the defendant Alexion Pharmaceuticals, Alexion Pharmaceuticals.

Case Details

    Case Number:

    App_33372/2025

    Patent Number:

    Filing Date:

    21 Jul, 2025

    Proceeding Type:

    Application

    Action/Application:

    Application Rop262A

    Plaintiffs:

    • Amgen
    • Amgen AB
    • Amgen Biofarmaceutica Lda.
    • Amgen Biofarmaceutica LDA
    • Amgen Inc.
    • Amgen Technology Ireland Unlimited
    • Amgen Technology (Ireland) Unlimited Company
    • Amgen Zdravila D.O.O.
    • Amgen Zdravila DOO

    Plaintiff Representatives:

    • Tilman Muller-Stoy

    Defendants:

    • Alexion Pharmaceuticals
    • Alexion Pharmaceuticals, Inc.

    Defendant Representatives:

    • Elena Hennecke

Case Decision

Decision pending - set alert to receive updates

Docket Entries

No docket found - set alert to stay updated on new entries.

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
App_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
App_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -

More cases involving Alexion Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_35353/2025Aug 22, 2025Alexion Pharmaceuticals -
ORD_35357/2025Aug 22, 2025Samsung BioepisAlexion Pharmaceuticals
App_35118/2025Aug 20, 2025Alexion Pharmaceuticals -